Sun Pharmaceutical (SUNPHARMA) — Corporate Governance

Sun Pharmaceutical submitted its FY 2024-25 ESG Overview covering 79% of operations and 98% of revenues across 38 key locations. The company maintains zero compliance violations (bribery, corruption, insider trading, environmental non-compliance). Trade association contributions doubled to ₹422.80 crores from ₹201.80 crores year-over-year. The 8-member Board has 62.5% independent directors with robust governance frameworks. Carbon emissions reduced 21% against a 35% 2030 target, while water consumption fell 25% versus 2020 baseline. R&D investment stands at 6.2% of revenues, supporting 19 clinical-stage molecules. Zero Class-1 recalls recorded; 20 Class-2 recalls with minimal product value impact.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,50,643.09 Cr P/E: 41.3 ROE: 15.1% ROCE: 20.3%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How does this corporate governance affect Sun Pharmaceutical Industries Limited's outlook?" "What did Sun Pharmaceutical Industries Limited announce on 14 October 2025?" "Is this positive or negative for SUNPHARMA?"

Ask AI Free →

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

🔥 Also filed on 14 October 2025

AMBUJACEM Ambuja Cements Limited Corporate Action AXISBANK Axis Bank Limited Corporate Action TECHM Tech Mahindra Limited Corporate Action TECHM Tech Mahindra Limited Corporate Action TECHM Tech Mahindra Limited Financial Results CHOLAFIN Cholamandalam Investment and Finance Company Limited Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.